Tech Company Financing Transactions
Correlia Biosystems Funding Round
Correlia Biosystems, based in Berkeley, secured $7 million in funding from NeoTribe Ventures, Cota Capital and The Regents of the University of California.
Transaction Overview
Company Name
Announced On
12/7/2020
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for the commercial launch of its immunoassay platform.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
626 Bancroft Way A
Berkeley, CA 94710
USA
Berkeley, CA 94710
USA
Phone
Undisclosed
Website
Email Address
Overview
Correlia Biosystems is a UC Berkeley spinoff company based out of the QB3@953 startup incubator in San Francisco. Correlia develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Akwasi Apori
Chief Scientific Officer
Samuel Tia
Chief Technical Officer
Kursad Araz
Browse more venture capital transactions:
Prev: 12/7/2020: Mekonos venture capital transaction
Next: 12/7/2020: MedArrive venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs